glp-1 side effects blindness 💉 Optometrists are warning drugs may pose these types of rare risks 💉 ⬇️ Details in comments Your guide to GLP-1 side

Vergs B, Charbonnel B

AMG133 (subcutaneous, every 4 weeks) is a monoclonal antibody that was designed to antagonise the GIP receptor and is also linked to two modified GLP-1 peptides that activate the GLP-1 receptor [58]

Exendin-4 could still exhibit stimulatory activity in the same setting, suggesting that either mTORC2 alone or both mTOR complexes must be blocked in order to completely abrogate GLP-1R signalling action on glycolysis

MS analyses were performed by the Proteomics Research Infrastructure (PRI) at the University of Copenhagen (UCPH), supported by the Novo Nordisk Foundation (NNF) (grant number NNF19SA0059305)

Liraglutide (Victoza)

What is the number needed to treat